James R. Tobin - Mar 4, 2022 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for James R. Tobin
Stock symbol
LYRA
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
4
Date filed
3/8/2022, 03:26 PM
Previous filing
Jan 31, 2022
Next filing
Mar 10, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable in 36 substantially equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following March 4, 2022.